• 1. MAY 2020
    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    AUTHORS: Olesova, D., Galba, J., Piestansky, J., Celusakova, H., Repiska, G., Babinska, K., Ostatnikova, D., Katina, S., Kovac, A.. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to
    • 20. JANUARY 2020
    Alteration of the steroidogenesis in boys with autism spectrum disorders

    Alteration of the steroidogenesis in boys with autism spectrum disorders

    AUTHORS: Jansakova, K., Hill, M., Celarova, D., Celusakova, H., Repiska, G., Bicikova, M., Macova, L., Ostatnikova, D. ABSTRACT: The etiology of autism spectrum disorders (ASD) remains unknown, but associations between prenatal hormonal changes and ASD risk were found. The consequences of these changes on the steroidogenesis during a postnatal development are not yet well known.